The Feldman Protocol

In this episode of The Feldman Protocol, can nutrition debates be clarified by better language? Amber O’Hearn, independent researcher and writer with a math/computer science background, makes the case across privacy tech, computational linguistics, low-carb history, carnivore nutrition, vitamin C, ketones, LDL, and the tension between anecdotes, mechanisms, and prospective data.🔥 This episode is...

In this episode of The Feldman Protocol, what happens when a health scare forces a second act? Chris Cornell, writer, marketer, and health coach, makes the case for low-carb living, satiety, resistance training, social support, cancer scares, GLP-1 drugs, and why lifestyle change often requires more than information alone. 🔥 This episode is sponsored by us -- Own Your Labs 👉 https://ownyourlabs....

In this episode of The Feldman Protocol, what happens when AI starts reshaping not just media, but the way people think, create, and connect? Claire Cornetta, co-founder and principal of Carrot Impact, joins Dave for a wide-ranging conversation on impact campaigns, the changing film business, AI and authenticity, social media’s effect on news, health communication, and why long-form storytelling s...

In this episode of The Feldman Protocol, what happens when a diet change succeeds where years of psychiatric treatment fall short? Matt Baszucki, metabolic mental health advocate and YouTube creator, makes the case from lived experience, discussing bipolar disorder, psychosis, ketogenic therapy, medication tapering, carnivore, and why metabolic approaches still struggle to break into mainstream ps...

In this episode of The Feldman Protocol, can heart disease prevention be asking the wrong question? Dave sits down with Philip Ovadia, MD, cardiothoracic surgeon, as the guest makes the case for looking beyond LDL alone. They discuss bypass surgery, why cholesterol-lowering hasn’t erased heart disease, insulin resistance, trial design, statins and PCSK9 drugs, real-food diets, CGMs, and how clinic...

In this episode of The Feldman Protocol, what does it take to turn a dense cholesterol debate into a film people can actually follow? Dave talks with Jennifer Isenhart, documentary director and writer, about making *Cholesterol Code*, translating complex science for a lay audience, weaving in personal stories, navigating four years of production twists, and reshaping the film as new data emerged....

In this episode of The Feldman Protocol, what happens when a midlife dietary change collides with decades of diagnosis, stigma, and trial-and-error? Guest Robyn Dobbins (lived-experience advocate, podcast host, health coach, and community coordinator at the nonprofit Metabolic Collective) makes the case for why personal narratives matter in metabolic mental-health advocacy—covering early symptoms,...

In this episode of The Feldman Protocol, what happens when a personal health experiment turns into a public-facing education project? Guest makes the case for practical, data-minded self-tracking while navigating online narratives and everyday constraints. Dave and Jenny Mitich (nutrition educator and author of *The Complete Carnivore*) discuss glucose monitoring, protein-to-fat adjustments, testi...

In this episode of The Feldman Protocol, Greg Mushen, a longtime technology and product leader turned independent health researcher, makes the case that disciplined thinking from Silicon Valley can meaningfully inform nutrition and metabolic health. The discussion also directly engages with debates raised by the Keto-CTA study, using it as a case example to examine data transparency, scientific cr...

In this episode of The Feldman Protocol, a core question hangs over the conversation: how did so many clinicians and patients miss low-carb interventions for so long? Dave sits down with Doug Reynolds, founder of Low Carb USA and president of the Society of Metabolic Health Practitioners, as the guest makes the case for carbohydrate reduction in chronic disease, practitioner education gaps, cultur...

In this episode of The Feldman Protocol, a provocative question anchors the conversation: how much of cardiovascular risk is about cholesterol itself versus the context it operates in? Guest **Josh Wageman, DPT, PA-C, PhD**—a clinical lipid specialist and researcher—makes the case for using metaphor, metabolic health, and imaging to think differently about risk. The discussion spans coronary calci...

In this episode of The Feldman Protocol, Dave asks: what happens when a fertility specialist-turned-health thinker questions nutrition narrative? Guest Robert Kiltz, MD , makes the case for animal-based diets, metabolic flexibility, mindset, faith and medicine, clinical experience vs. guidelines, and the role of community. The conversation ranges from physiology and lipid metabolism to entrepreneu...

In this episode of The Feldman Protocol, Dave asks a blunt question: is modern medicine structurally aligned against prevention? Guest **Emily Kaplan**, investigative science journalist and co-founder of the Broken Science Initiative, makes the case that incentives, not evidence, increasingly shape medical practice. They discuss conflicts of interest in research, the reproducibility crisis, metabo...

In this episode of The Feldman Protocol, a central question hangs over the conversation: what actually causes a heart attack when standard risk markers look “normal”? Guest Dr. Stephen Hussey, DC (functional medicine practitioner focused on cardiovascular disease), makes the case for re-examining core assumptions about heart disease. Topics include plaque vs. risk, LDL cholesterol, CAC scoring, st...

In this episode of The Feldman Protocol, we ask: What happens when clinical guidelines collides with messy real-world outcomes? Guest Bret Scher, MD, makes the case for rethinking metabolic health, evidence hierarchies, clinical incentives, LDL interpretation, ketogenic therapies, guideline rigidity, psychiatric applications of metabolic interventions, and his own evolution from cardiologist to me...

In this episode of The Feldman Protocol, what if a single overlooked nutrient could meaningfully alter how we think about chronic illness? Guest Dr. Darren Schmidt (DC, nutrition-focused clinician) makes the case for the role of B1 deficiency, discusses environmental toxic exposures, explores mitochondrial dysfunction, and examines lactic acidosis as a framework for understanding complex disease p...

In this episode of The Feldman Protocol, can you truly build muscle and maintain health with just 15 minutes of exercise twice a week? Dave chats with Ben Bocchicchio, PhD in Exercise Physiology and Health, who makes the case for slow-motion resistance training as the ultimate efficiency hack. Guest explores mitochondrial optimization through high-intensity exercise, addresses middle-age workout m...

In this episode of The Feldman Protocol, special guest Mike Mutzel explores groundbreaking research on the immune system, GLP-1, the gut microbiome and lean mass hyper-responders. They deep dive on the Lipid Energy Model, atherosclerosis mechanisms, immune system interactions, coronary artery imaging data, and conventional cardiovascular risk paradigms in metabolic health. 🔥 This episode is spons...

In this episode, Dave sits down with Austin, a metabolic data enthusiast and early adopter of continuous glucose monitoring (CGM) who brings a fascinating blend of self-experimentation, performance optimization, and deep curiosity about human physiology. From endurance training to dietary tracking, Austin shares his journey through the data-driven side of health — how he uses CGM, heart rate, and...

In this episode, Dave sits down with Peter Ballerstedt, a retired forage agronomist and ruminant nutritionist known as "Don Pedro the Sod Father of the Ruminati," who brings a unique agricultural perspective to metabolic health discussions. Ballerstedt shares his 2007 transformation after reading Gary Taubes' book and how it led him to bridge agricultural science with the low-carb co...

In this episode, Dave sits down with Dr. Eric Westman, associate professor of medicine at Duke University and founder of the Keto Medicine Clinic, who has built his practice around using dietary interventions to treat patients. Dr. Westman discusses his path from traditional internal medicine to researching low-carb approaches, including his early observations of patients whose cholesterol profile...

Can we really justify what we eat today by pointing to what our ancestors ate thousands of years ago? In this thought-provoking episode, I sit down with Alex Leaf, a scientific communicator and longtime researcher with Examine.com, to challenge some of the most persistent ideas in nutrition. We dive deep into the ancestral argument, the role of mTOR and protein in longevity, and the personal fat t...

In this episode of The Feldman Protocol, Dave Feldman sits down with Nicholas Verhoeven PhD, the creator of @Physionic and recent molecular medicine graduate who has successfully transitioned from traditional academia to independent science communication. The conversation explores Nic's unique approach to content creation, including his decision to reject thousands of sponsorship offers to mai...

In Part 3 of this episode of The Feldman Protocol, Dave Feldman concludes his conversation with Nick Norwitz MD PhD, exploring thought-provoking topics that span from practical health assessments to philosophical questions about consciousness. The discussion covers Nick's analysis of Peter Attia's evolving stance on lipids, Bryan Johnson's controversial decision to avoid CTA scans due...

In Part 2 of this episode of The Feldman Protocol, Dave Feldman continues his conversation with Nick Norwitz, focusing on controversial topics that showcase Nick's scientific rigor. The discussion begins with Nick's methodical critique of Bryan Johnson's longevity claims, questioning his scientific methodology and the lack of transparency in his $2 million annual protocol. Nick explore...